TSX:HLS (HLS Therapeutics Inc.)

About HLS

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.
  • HLS Therapeutics Inc. (TSX: HLS) Latest News

    Cannabis Stocks

    3 Pot Stocks Robinhood Investors Should Buy Instead of Aurora Cannabis (TSX:ACB)

    It's time to look beyond pot stocks such as Aurora Cannabis (TSX:ACB) and instead invest in profitable marijuana players.

    Read more »

    Cannabis Stocks

    3 Pot Stocks That Can Soar After Q3 Earnings

    Pot stocks such as Turlieve Cannabis (CNSX:TRUL) have the potential to end 2020 on a high if they beat market…

    Read more »

    Cannabis Stocks

    Why Is This Pot Stock Crushing Canopy Growth (TSX:WEED) in 2020?

    While Canopy Growth (TSX:WEED) stock is struggling with negative profit margins and sluggish revenue growth, Trulieve is beating this trend…

    Read more »

    Cannabis Stocks

    Got $1,000? Here’s the Top Pot Stock to Buy Right Now

    Trulieve Cannabis (CNSX:TRUL) is a billion-dollar pot stock that has multiple growth drivers to increase investor wealth in the long-term.

    Read more »

    Cannabis Stocks

    Better Than Canopy Growth (TSX:WEED): This Red-Hot Pot Stock Is Already up 70% in 2020

    Rather than investing in a risky stock like Canopy Growth Corp (TSX:WEED)(NYSE:CGC), buy shares of this company instead.

    Read more »

    Cannabis Stocks

    TFSA Investors: Is it Time to Bet on This Billion-Dollar Pot Stock?

    Here's why Trulieve Cannabis stock is a solid bet for TFSA investors.

    Read more »

    Cannabis Stocks

    2 Reasons Why This Top Cannabis Company Might Be a Buy

    Trulieve Cannabis Corp (CNSX:TRUL) isn’t the most popular pot company, but the firm is definitely worth considering.

    Read more »